Huntington Bancshares Incorporated (HBAN) valuation

Share price $16.40 · Close 2026-04-24

Price-to-Earnings

P/E · Trailing Diluted
11.80×
P/E history →

Price-to-Free-Cash-Flow

P/FCF · Trailing
11.14×
P/FCF history →

Free-Cash-Flow Yield

FCF Yield · Trailing
8.98%
FCF Yield history →

Enterprise-Value-to-EBITDA

EV/EBITDA · Trailing
EV/EBITDA history →

Price-to-Sales

P/S · Trailing
16.46×
P/S history →

Price-to-Book

P/B · Latest filing
1.06×
P/B history →

Expectations investing: what does the price imply?

Near-consensus — no material stretch

Rappaport-style reverse-DCF. We start from the current market price ($16.40 × 1.57B shares = $25.71B market cap, $29.87B enterprise value) and solve for the operating path that would justify it.

To reconcile today's price with a plausible scenario, the model lands on:

  • Year-1 revenue growth: 60.0%
    Scenario holds the analyst consensus of 60.0%.
  • Target EBIT margin (Y10): 174.1%
    Scenario starts 172.1%, ends 174.1% (3-yr range 163.7%–172.1%).
  • High-growth plateau: 3 years
    Tier default for Y2 at 10.0%.
  • Starting ROIC held at 7.8% for Y1–Y5
    Recent CapEx 1.46× the 3-yr mean — the scenario credits that investment with future returns, holding ROIC at 7.8% through the harvest window before fading to terminal 11.0%.

at or below the reference above the reference outside the historical band

Where the PV comes from
Y1–3
-77%
Y4–10
-15%
Terminal
+192%

Share of the total PV the model has assigned to each window. The further out a cash flow sits, the harder it is to estimate — so readers can weigh how much of the scenario rests on the near, plateau, and post-horizon periods.

Facts · FY2025 (2025-12-31)

Share price
$16.40
Diluted shares
1.57B
Total debt
$17.66B
Cash & equivalents
$13.49B
Revenue
$1.56B
Pretax income (cont. ops)
$2.69B
Filer does not tag us-gaap:OperatingIncomeLoss; using pretax income from continuing operations as the operating-income base. For banks this is effectively operating income (interest expense is a core cost); for oil majors and some pharma filers it's a close proxy with small non-operating items mixed in.
Pretax margin
172.1%
Operating cash flow
$2.48B
CapEx
$267.0M
Observed YoY growth
6.4%
Analyst current-FY growth
38.0%
Analyst next-FY growth
10.0%
3-year revenue CAGR
5.8%

Assumptions

Initial revenue growth
60.0%
from analyst consensus
Year-2 growth
10.0%
from analyst next-FY consensus
Starting EBIT margin
172.1%
from latest FY EBIT margin (GAAP)
Tax rate
17.3%
from 3-year median of EffectiveTaxRate
Starting ROIC
7.8%
NOPAT₀ ÷ invested capital, capped at 40.0%

Constants

Horizon
10 years
WACC
9.0%
Terminal growth
2.5%
Terminal ROIC
11.0%

Yearly projection

Year Revenue Growth EBIT Margin NOPAT ROIC Reinvestment FCF Discount PV of FCF
1 $2.50B 60.0% $4.31B 172.3% $3.56B 7.8% $17.16B -$13.60B 0.917 -$12.47B
2 $3.05B 22.0% $5.26B 172.5% $4.35B 7.8% $10.13B -$5.78B 0.842 -$4.86B
3 $3.72B 22.0% $6.43B 172.7% $5.31B 7.8% $12.37B -$7.06B 0.772 -$5.45B
4 $4.44B 19.2% $7.67B 172.9% $6.34B 7.8% $13.21B -$6.87B 0.708 -$4.87B
5 $5.17B 16.5% $8.95B 173.1% $7.40B 7.8% $13.50B -$6.10B 0.650 -$3.97B
6 $5.88B 13.7% $10.18B 173.3% $8.42B 8.4% $12.10B -$3.68B 0.596 -$2.19B
7 $6.51B 10.9% $11.30B 173.5% $9.34B 9.1% $10.20B -$857.7M 0.547 -$469.2M
8 $7.04B 8.1% $12.23B 173.7% $10.11B 9.7% $7.89B $2.22B 0.502 $1.11B
9 $7.41B 5.3% $12.89B 173.9% $10.66B 10.4% $5.28B $5.38B 0.460 $2.47B
10 $7.60B 2.5% $13.23B 174.1% $10.94B 11.0% $2.54B $8.40B 0.422 $3.55B
Sum of PV of FCF (years 1-10) -$27.15B

Terminal value

NOPATN+1
$11.21B
ReinvestmentN+1
$2.49B
FCFN+1
$8.72B
Terminal value (undiscounted)
$134.22B
PV of terminal value
$56.70B
Gordon-growth: TV = FCFN+1 ÷ (WACC − g) = $8.72B ÷ (9.0% − 2.5%).

Equity bridge

PV of operating FCF -$27.15B
+ PV of terminal value $56.70B
= Enterprise value $29.55B
− Total debt $17.66B
+ Cash & equivalents $13.49B
= Equity value $25.39B
÷ Diluted shares 1.57B
= DCF PV / share $16.20
Market price $16.40
Reconciliation delta −1.2% (≈ 0 by construction)
Full calculation trail Click to expand — every number on this page derived step by step.

1 · Enterprise-value target (what the DCF must match)

Market cap   = price × diluted shares
             = $16.40 × 1.57B
             = $25.71B

EV target    = market cap + total debt − cash & equivalents
             = $25.71B + $17.66B − $13.49B
             = $29.87B
            

2 · Starting NOPAT (base year 0)

GAAP EBIT          = $2.69B   (172.1% of revenue)
× (1 − tax rate)  = × (1 − 17.3%) = × 0.8268
= NOPAT₀            = $2.22B
            

3 · Invested capital & starting ROIC

Invested capital = total debt + book equity − cash
                 = $17.66B + $24.34B − $13.49B
                 = $28.50B

Raw ROIC₀        = NOPAT₀ / Invested capital
                 = $2.22B / $28.50B
                 = 7.8%
(no cap applied; raw value is within the 40.0% ceiling)
            

4 · Growth path construction

Source       = analyst consensus: Y1 = 60.0%, Y2 = 10.0%
Clamp        = [2.5%, 60%] (no sub-terminal or 60%+ starts)
Plateau rate = 10.0% (Y2 — held from year 2 through end of plateau)
Tier         = 3 years (rule: plateau rate < 15% → 3y, < 25% → 5y, else 7y)
Plateau      = 3 years
Fade         = linear from effective Y2 to terminal 2.5% across the remaining 7 years

Effective Y1 growth after solver bumps = 60.0%
Effective Y2 growth after solver bumps = 10.0%
Growth by year:
  Y1 = 60.0%
  Y2 = 22.0%
  Y3 = 22.0%
  Y4 = 19.2%
  Y5 = 16.5%
  Y6 = 13.7%
  Y7 = 10.9%
  Y8 = 8.1%
  Y9 = 5.3%
  Y10 = 2.5%
            

5 · Margin path construction

Starting margin (Y0) = 172.1%   (source: latest FY EBIT margin (GAAP))
Target margin (Y10)  = 174.1%   (solver output, normal band)
Year-t margin        = starting + (target − starting) × (t / 10)
Margin by year:
  Y1 = 172.3%
  Y2 = 172.5%
  Y3 = 172.7%
  Y4 = 172.9%
  Y5 = 173.1%
  Y6 = 173.3%
  Y7 = 173.5%
  Y8 = 173.7%
  Y9 = 173.9%
  Y10 = 174.1%
            

6 · ROIC path construction

The capex heuristic compares latest-period CapEx ($267.0M) against the Normalized CapEx (3-yr mean) of $183.3M — mean of the last three annual CapEx values. When the latest is above 1.4× that mean and CapEx is at least 5% of revenue, we treat the filer as capital-intensive and mid-investment, hold ROIC flat for a 5-year harvest phase, and only then fade to terminal ROIC. The 3-yr mean does not feed the DCF directly — it only gates this flag.

Capex-heuristic active (latest CapEx 1.46× the 3-yr mean of $183.3M).
Y1..Y5  held at ROIC₀ = 7.8%
Y6..Y10 fade linearly to ROIC_terminal = 11.0%

ROIC by year:
  Y1 = 7.8%
  Y2 = 7.8%
  Y3 = 7.8%
  Y4 = 7.8%
  Y5 = 7.8%
  Y6 = 8.4%
  Y7 = 9.1%
  Y8 = 9.7%
  Y9 = 10.4%
  Y10 = 11.0%
            

7 · Solver iterations

Each row is one bisection attempt. The solver sweeps Y1 growth bumps 0pp → +20pp across the plateau ladder inside the normal margin bracket, then — if nothing reconciles — repeats the same sweep in a widened margin band ([-10%, 80%]). The first feasible attempt is the one the page uses. If no combination reconciles, the page shows the attempt whose PV sits closest to the target EV so both levers are balanced.

# Phase Plateau Y1 bump Solved margin PV(EV) vs target Feasible?
1 normal 3y +0pp 174.1% $27.11B −9.2% no
2 normal 3y +2pp 174.1% $27.41B −8.2% no
3 normal 3y +4pp 174.1% $27.75B −7.1% no
4 normal 3y +6pp 174.1% $28.13B −5.8% no
5 normal 3y +8pp 174.1% $28.56B −4.4% no
6 normal 3y +10pp 174.1% $29.03B −2.8% no
7 normal 3y +12pp 174.1% $29.55B −1.1% yes ✓

8 · Terminal value derivation

NOPAT_{N+1}         = NOPAT_{10} × (1 + g_terminal)
                    = $10.94B × (1 + 2.5%)
                    = $11.21B

ΔNOPAT              = NOPAT_{N+1} − NOPAT_{10}
                    = $273.4M
Reinvestment_{N+1}  = ΔNOPAT / ROIC_terminal
                    = $273.4M / 11.0%
                    = $2.49B

FCF_{N+1}           = NOPAT_{N+1} − Reinvestment_{N+1}
                    = $11.21B − $2.49B
                    = $8.72B

Terminal value (TV) = FCF_{N+1} / (WACC − g_terminal)
                    = $8.72B / (9.0% − 2.5%)
                    = $134.22B

PV(TV)              = TV / (1 + WACC)^10
                    = $134.22B / 2.367
                    = $56.70B
            

9 · Reconciliation check (DCF PV vs. the market)

This isn't a fair value — it's the inverse check. The solver built the scenario so that DCF PV reproduces the current enterprise value; if the normal bracket worked the delta below is ~0 by construction. A non-zero delta only appears when the solver fell through to the widened margin band.

Σ PV(FCF_1..10) = -$27.15B
+ PV(TV)          = $56.70B
= Enterprise value = $29.55B   (≈ EV target $29.87B by construction)
− Total debt      = $17.66B
+ Cash            = $13.49B
= Equity value    = $25.39B
÷ Diluted shares  = 1.57B
= DCF PV / share  = $16.20

Market price      = $16.40
Reconciliation Δ  = −1.2%   (≈ 0 by construction — the solver anchored on this price)
            
Open this scenario in the calculator →
Every input above is pre-filled; the calculator auto-runs and lets you override any assumption.

Every rule above — growth-source priority, plateau tiers, compound cap, solver ladder, flag colours — is documented on the expectations scenario methodology.

What these ratios mean & how they're built: see the valuation ratios glossary on the company-facts methodology page — per-ratio definitions and the exact us-gaap concepts behind each numerator and denominator.

Sources. Denominators come from SEC EDGAR XBRL filings for HBAN (CIK 0000049196); analyst growth forecasts come from analyst consensus. Share price is the latest split-adjusted close from our daily history (live quote as fallback). Per-share denominators are split-adjusted to today's share count.